Intellectual Property India Publishes Patent Application for 'Intraluminal Stent With Handle For Treating Benign Prostatic Hyperplasia' Filed by Rivermark Medical, Inc.

MUMBAI, India, June 6 -- Intellectual Property India has published a patent application (202517038665 A) filed by Rivermark Medical, Inc., Milwaukee, U.S.A., on April 22, for 'intraluminal stent with handle for treating benign prostatic hyperplasia.'

Inventor(s) include Kadlec, Adam; Doraiswamy, Anand; Schieber, Andrew; Souza, Marcus; and Chu, Nathan.

The application for the patent was published on June 6, under issue no. 23/2025.

According to the abstract released by the Intellectual Property India: "A stent is disclosed that is configured to maintain patency of the prostatic urethra despite an enlarged prostate. The stent can include a handle that, in an undeflected position, is disposed outside of the flow path of the stent. When the handle is pulled, the handle can deflect to generally aligned with a central axis of the stent. A capture device is disclosed that includes a tapered tip to navigate a working channel of a delivery device and a hook that can capture the stent handle and be moved into a tube to retain the stent handle to facilitate maneuvering of the stent in and out of the working channel of the delivery device. A loading adapter with a tapered port is disclosed that can be disposed on the delivery device to distribute compressive forces applied by the port on the stent during loading into the working channel."

The patent application was internationally filed on Sept. 22, 2023, under International application No.PCT/US2023/074925.

Disclaimer: Curated by HT Syndication.